Researcher index

Authors in the psilocybin and psilocin literature

Search researcher names, inspect publication history, find recurring topics, and create author watch alerts without collecting unverified contact lists.

Francisco A Moreno

16 indexed publications match this author name.

ORCID: 0009-0008-0700-6508
OpenAlex: https://openalex.org/A5136049237

Author watchlist

Create a confirmed email alert for new publications matching this author.

Topics

Safety 8 Receptor Pharmacology 8 OCD 5 Review Article 5 Mechanism of Action 4 Animal Study 4 Adverse Events 3 Consciousness 3 Wellbeing 2 Drug Interactions 2 Observational Study 1 Brain Imaging 1

Journals

ClinicalTrials.gov 2 Neuroscience letters 2 Frontiers in Psychiatry 1 Journal of Psychopharmacology 1 Psychedelic medicine (New Rochelle, N.Y.) 1 Clinical neuropharmacology 1 Addiction biology 1 Letters in Applied NanoBioScience 1

Publication history

A Randomized Double-masked Dose-controlled Trial to Assess the Tolerability, Safety, Subjective Experience, and Efficacy of Repeated Administration of Three Different Doses of Psilocybin Whole Mushroom for the Treatment of Obsessive-compulsive Disorder.ClinicalTrials.gov · 2026-07-23 Inaugural year of regulated psilocybin services in Oregon: safety, motivations, and utilizationFrontiers in Psychiatry · 2026-05-13 Psilocybin for Treatment of Obsessive Compulsive DisorderClinicalTrials.gov · 2026-05-12 A randomized clinical trial of repeated doses of psilocybin for the treatment of obsessive-compulsive disorderJournal of Psychopharmacology · 2026-05-01 A Field-Wide Review and Analysis of Study Materials Used in Psilocybin Trials: Assessment of Two Decades of Research.Psychedelic medicine (New Rochelle, N.Y.) · 2025-03-01 Psilocybin Use in the Autism Spectrum Disorder: A Scoping Review.Clinical neuropharmacology · 2025-01-01 Classic psychedelics and alcohol use disorders: A systematic review of human and animal studies.Addiction biology · 2022-11-01 Molecular Structure, Reactivity and Spectroscopic Properties of Hallucinogens Psilocybin, Mescaline and their Derivatives - A Computational StudyLetters in Applied NanoBioScience · 2022-09-17 Combining FTIR-ATR and OPLS-DA methods for magic mushrooms discriminationForensic Chemistry · 2022-04-08 184. Hallucinogens on TikTokJournal of Adolescent Health · 2022-03-10 Psilocybin for the Treatment of Obsessive-Compulsive Disorders.Current topics in behavioral neurosciences · 2022-01-01 P.0729 Highlights of psychedelic history and current research on psilocybin application for treatment of depression - a comprehensive literature reviewEuropean Neuropsychopharmacology · 2021-12-01 Chronic treatment with LY341495 decreases 5-HT(2A) receptor binding and hallucinogenic effects of LSD in mice.Neuroscience letters · 2013-03-01 Metabotropic glutamate mGlu2 receptor is necessary for the pharmacological and behavioral effects induced by hallucinogenic 5-HT2A receptor agonists.Neuroscience letters · 2011-04-15 Maternal influenza viral infection causes schizophrenia-like alterations of 5-HT₂A and mGlu₂ receptors in the adult offspring.The Journal of neuroscience: the official journal of the Society for Neuroscience · 2011-02-02 Safety, tolerability, and efficacy of psilocybin in 9 patients with obsessive-compulsive disorder.The Journal of clinical psychiatry · 2006-11-01

Author directory